135 related articles for article (PubMed ID: 31508989)
1. Gynaecomastia: a cosmetic concern or a concerning clinical sign?
Whitehead IJ; Fernandes L; Haris O; Chagla L
Ann R Coll Surg Engl; 2019 Nov; 101(8):e184-e186. PubMed ID: 31508989
[TBL] [Abstract][Full Text] [Related]
2. [Three patients with gynaecomastia].
Walraven M; Wilmink HJ; de Boer LM; Muller AF
Ned Tijdschr Geneeskd; 2004 Apr; 148(17):809-13. PubMed ID: 15141644
[TBL] [Abstract][Full Text] [Related]
3. Prolactinoma can be associated with gynecomastia.
Cohen PR; Robinson FW; Gray JM
Skinmed; 2010; 8(4):201-2. PubMed ID: 21137603
[No Abstract] [Full Text] [Related]
4. Giant, solid, invasive prolactinoma in a prepubescent boy with gynecomastia.
Furtado SV; Saikiran NA; Ghosal N; Hegde AS
Pediatr Neurol; 2010 Jan; 42(1):72-4. PubMed ID: 20004869
[TBL] [Abstract][Full Text] [Related]
5. Ventriculitis from a pituitary prolactinoma: bacterial or chemical?
Jayasekera BA; Hall J; Pearce S; Jenkins AJ
Br J Neurosurg; 2017 Apr; 31(2):262-263. PubMed ID: 27400138
[TBL] [Abstract][Full Text] [Related]
6. Gynaecomastia: is one cause enough?
Creyghton WM; Custers M
Neth J Med; 2004; 62(7):257-9. PubMed ID: 15554602
[TBL] [Abstract][Full Text] [Related]
7. Gynecomastia: when is treatment indicated?
Morcos RN; Kizy T
J Fam Pract; 2012 Dec; 61(12):719-25. PubMed ID: 23313989
[TBL] [Abstract][Full Text] [Related]
8. A case of atypical macroprolactinoma presenting with pituitary apoplexy during pregnancy and review of the literature.
Oguz SH; Soylemezoglu F; Dagdelen S; Erbas T
Gynecol Endocrinol; 2020 Feb; 36(2):109-116. PubMed ID: 31389277
[TBL] [Abstract][Full Text] [Related]
9. Is it reasonable to do endocrine investigation in unilateral gynecomastia?
Fathi AR
Ann Plast Surg; 2007 Oct; 59(4):475. PubMed ID: 17901747
[No Abstract] [Full Text] [Related]
10. Cystic degeneration of macroprolactinoma on long-term cabergoline.
Sharif DA; Nkonge FM; Chawda S; Benjamin J; Stojanović ND
J Clin Endocrinol Metab; 2010 Aug; 95(8):3593-4. PubMed ID: 20685886
[No Abstract] [Full Text] [Related]
11. Pituitary apoplexy in a patient with prolactinoma following computerized tomography scan.
Abend Y; Attali M; Barzilay N; Geltner D
Eur J Med; 1992 Nov; 1(7):439-40. PubMed ID: 1341487
[No Abstract] [Full Text] [Related]
12. Fifteen-Year-Old Female With Delayed Progression of Puberty and Visual Disturbances.
Akhtar S; Patel L; Bakhach M; Haider A; Gonzalez-Martinez J; Rogers D; Tsilianidis L; Raissouni N; Schweiger M
Clin Pediatr (Phila); 2016 Jun; 55(7):664-7. PubMed ID: 26581351
[No Abstract] [Full Text] [Related]
13. [Bromocriptine monotherapy of a prolactinoma causing erectile dysfunction].
López Cubillana P; Hita Rosino E; Asensio Egea L; Rigabert Montiel M; Hita Villaplana G; Server Pastor G; Server Falgás G
Arch Esp Urol; 1997 Jun; 50(5):526-8. PubMed ID: 9382597
[TBL] [Abstract][Full Text] [Related]
14. Atypical giant prolactinoma with frontal lobe manifestations.
Arshad MF; Arambewela M; Debono M
BMJ Case Rep; 2018 Sep; 2018():. PubMed ID: 30181411
[No Abstract] [Full Text] [Related]
15. [Macroprolactinoma with galactorrhea in a 13-year-old girl].
Benacková H; Krák E
Cesk Pediatr; 1992 Oct; 47(10):605-8. PubMed ID: 1464090
[TBL] [Abstract][Full Text] [Related]
16. Giant prolactinoma, germline BRCA1 mutation, and depression: a case report.
Bettencourt-Silva R; Queirós J; Pereira J; Carvalho D
J Med Case Rep; 2018 Dec; 12(1):360. PubMed ID: 30518416
[TBL] [Abstract][Full Text] [Related]
17. Fluctuating confusional state due to massive macro-prolactinoma resulting in obstructive hydrocephalus.
Sarkar PK; Manapuzha R; Ahmad S; Ritch AE
Age Ageing; 2001 Sep; 30(5):426-8. PubMed ID: 11709386
[No Abstract] [Full Text] [Related]
18. Acromegaly with normal basal growth hormone levels.
Mohr G; Chen ZP; Schweitzer M
Can J Neurol Sci; 1997 Aug; 24(3):250-3. PubMed ID: 9276113
[TBL] [Abstract][Full Text] [Related]
19. Prolactinoma and systemic lupus erythematosus: do serum prolactin levels matter?
Li M; Keiser HD; Peeva E
Clin Rheumatol; 2006 Jul; 25(4):602-5. PubMed ID: 16404500
[TBL] [Abstract][Full Text] [Related]
20. Bromocriptine as a Potential Glucose-lowering Agent for the Treatment of Prolactinoma with Type 2 Diabetes.
Oshige T; Nakamura Y; Sasaki Y; Kawano S; Ohki T; Tsuruta M; Tokubuchi I; Nakayama H; Yamada K; Ashida K; Tajiri Y; Nomura M
Intern Med; 2019 Nov; 58(21):3125-3128. PubMed ID: 31243214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
